Close
4

Quotient Sciences Quotient Sciences

X

Company profile for MetrioPharm

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
MetrioPharm AG is a pharmaceutical development company focusing on therapies for chronic inflammatory diseases. We are developing a new class of self-regulating drugs against cellular oxidative stress. Oxidative stress is one of the central causes of chronic inflammation, triggering a variety of diseases such as arthritis, dementia, cardiovascular disease and other degenerative age-related indications. MetrioPharm AGs develop...
MetrioPharm AG is a pharmaceutical development company focusing on therapies for chronic inflammatory diseases. We are developing a new class of self-regulating drugs against cellular oxidative stress. Oxidative stress is one of the central causes of chronic inflammation, triggering a variety of diseases such as arthritis, dementia, cardiovascular disease and other degenerative age-related indications. MetrioPharm AGs development strategy is aimed specifically at these age-related inflammatory conditions. Our lead compound MP1032 is in Phase II clinical development and has demonstrated therapeutic efficacy and an exceptional.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
MetrioPharm
Switzerland Flag
Country
Country
Switzerland
Address
Address
Bleicherweg 10 8002 Zurich
Telephone
Telephone
+41 44 562 03 35
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY